{"id":140234,"date":"2026-04-20T08:50:05","date_gmt":"2026-04-20T08:50:05","guid":{"rendered":"https:\/\/my.legal500.com\/guides\/?post_type=comparative_guide&#038;p=140234"},"modified":"2026-04-20T08:50:29","modified_gmt":"2026-04-20T08:50:29","slug":"turkiye-venture-capital","status":"publish","type":"comparative_guide","link":"https:\/\/my.legal500.com\/guides\/chapter\/turkiye-venture-capital\/","title":{"rendered":"Turkey: Venture Capital"},"content":{"rendered":"","protected":false},"template":"","class_list":["post-140234","comparative_guide","type-comparative_guide","status-publish","hentry","guides-venture-capital","jurisdictions-turkiye"],"acf":[],"appp":{"post_list":{"below_title":"<div class=\"guide-author-details\"><span class=\"guide-author\">Fidanc\u0131 &amp; Esin Partners<\/span><span class=\"guide-author-logo\"><img src=\"https:\/\/my.legal500.com\/guides\/wp-content\/uploads\/sites\/1\/2026\/04\/fande-logo.jpg\"\/><\/span><\/div>"},"post_detail":{"above_title":"<div class=\"guide-author-details\"><span class=\"guide-author\">Fidanc\u0131 &amp; Esin Partners<\/span><span class=\"guide-author-logo\"><img src=\"https:\/\/my.legal500.com\/guides\/wp-content\/uploads\/sites\/1\/2026\/04\/fande-logo.jpg\"\/><\/span><\/div>","below_title":"<span class=\"guide-intro\">This country specific Q&amp;A provides an overview of Venture Capital laws and regulations applicable in Turkey<\/span><div class=\"guide-content\"><div class=\"filter\">\r\n\r\n\t\t\t\t<input type=\"text\" placeholder=\"Search questions and answers...\" class=\"filter-container__search-field\">\r\n\t\t\t<\/div>\r\n\r\n\t\t\t\r\n\r\n\r\n\t\t\t<ol class=\"custom-counter\">\r\n\r\n\t\t\t\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">Are there specific legal requirements or preferences regarding the choice of entity and\/or equity structure for early-stage businesses that are seeking venture capital funding in the jurisdiction?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>No, Turkish law imposes no specific legal requirements mandating a particular entity type or equity structure for early-stage businesses seeking venture capital funding.<\/p>\n<p>Both limited liability companies (limited \u015firket) and joint stock companies (anonim \u015firket) are fully eligible to receive VC investment. In practice, however, there is a strong market preference for the joint stock company form once institutional funding rounds are contemplated. Founders frequently incorporate as a LLC for its lower minimum capital (TRY 50,000), simpler management and reduced compliance costs, then convert to an JSC (minimum capital TRY 250,000) prior to the first significant VC round. The conversion process is straightforward and tax-neutral in most cases.<\/p>\n<p>The JSC is preferred for three main reasons:<\/p>\n<p>\u2022 Greater flexibility in share transfers and capital raises (including the registered capital system, which allows the board to issue new shares up to a pre-approved ceiling without repeated general assembly approvals).<\/p>\n<ul>\n<li>The ability to create different classes of shares with preferential rights (liquidation preference, enhanced voting, veto rights, etc.) that align with standard VC term sheets.<\/li>\n<li>A more institutional governance structure (board of directors) that international and domestic VC funds expect and that facilitates future exits, including IPOs.<\/li>\n<\/ul>\n<p>A further and significant advantage of the JSC is a tax exemption that does not apply to LLC capital shares. Under Repeated Article 80(1) of the Income Tax Law, capital gains realised by Turkish-resident individuals on the sale of JSC shares are fully exempt from income tax if (i) the shares are represented by duly issued share certificates and (ii) the shares have been held for more than two full calendar years. No equivalent exemption exists for LLC shares.<\/p>\n<p>In short, while either entity may be used, market practice and investor expectations mean that VC-backed companies in T\u00fcrkiye are almost invariably structured (or converted) as JSCs before closing an institutional round.<\/p>\n<p>Note: An additional legal requirement applies where investment is made through a Venture Capital Investment Fund. Pursuant to Article 18(2) of the Capital Markets Board Communiqu\u00e9 No. III-52.4 on Venture Capital Investment Funds (as amended), portfolio companies established in T\u00fcrkiye that are LLCs as at the date of the first investment must complete their conversion into JSC within one year following that investment date. No such conversion obligation applies to companies established outside T\u00fcrkiye. Venture capital investment funds may invest only in JSCs and LLCs; other entity types (such as cooperatives or ordinary partnerships) do not qualify as eligible portfolio companies.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What are the principal legal documents for a venture capital equity investment in the jurisdiction and are any of them publicly filed or otherwise available to the public?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>The principal legal documents for a venture capital equity investment in T\u00fcrkiye are the share subscription agreement (or share purchase agreement in the case of a secondary sale), the shareholders\u2019 agreement and the amended articles of association of the investee company.<\/p>\n<p>The share subscription agreement sets out the investment terms (number and class of shares, price, closing conditions, representations and warranties). The shareholders\u2019 agreement contains the investor protections and governance arrangements (board seats, veto rights, drag\/tag-along, anti-dilution, information rights, exit provisions, etc.). The articles of association are amended to reflect new share classes and any provisions that must be public.<\/p>\n<p>Only the amended articles of association and the related general assembly and board resolutions (approving the capital increase, investment, and any board changes) are filed with the Trade Registry Directorate and published in the Trade Registry Gazette; these are therefore publicly available. The share subscription agreement and the shareholders\u2019 agreement remain private and are not filed or available to the public.<\/p>\n<p>If the investment includes a change in board composition, the following additional public steps occur immediately after closing:<\/p>\n<ul>\n<li>A general assembly resolution elects the new board of directors<\/li>\n<li>The newly elected board then passes a resolution allocating duties among directors and determining representation powers (who may bind the company).<\/li>\n<\/ul>\n<p>Both the general assembly and board resolutions are filed with the Trade Registry and published in the Trade Registry Gazette.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">Is there a venture capital industry body in the jurisdiction and, if so, does it provide template investment documents? If so, how common is it to deviate from such templates and does this evolve as companies move from seed to larger rounds?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>T\u00fcrkiye has sector organisations relevant to the venture capital market, most notably G\u0130SED (Giri\u015fim Sermayesi Fonlar\u0131 Derne\u011fi), but it does not currently have a domestic equivalent of the NVCA or BVCA whose model investment documents function as the market standard. In practice, Turkish venture financings are documented primarily on the basis of law firm precedents and transaction-specific drafting, rather than industry-body templates.<\/p>\n<p>At seed stage, documentation is often kept relatively lean and may borrow from foreign precedents, including US or UK style seed or convertible instruments, but these forms are typically adapted to Turkish corporate law and market practice. In priced rounds, especially from Series A onwards, the documents become more bespoke and more heavily negotiated. Deviation from any starting template is therefore common in T\u00fcrkiye and generally increases as companies progress to larger rounds, where governance, liquidation preferences, transfer restrictions, anti-dilution protection, founder vesting and exit mechanics are negotiated in greater detail.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">Are there any general merger control, anti-trust\/competition and\/or foreign direct investment regimes applicable to venture capital investments in the jurisdiction?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Yes. Venture capital investments in T\u00fcrkiye may be subject to the general merger control regime under Law No. 4054 on the Protection of Competition and Communiqu\u00e9 No. 2010\/4. There is no venture-capital-specific filing regime, but a transaction may require prior clearance from the Turkish Competition Authority if it results in a lasting change of control, including joint control, and the applicable turnover thresholds are met. This may include minority investments where the investor acquires decisive influence through governance or veto rights.<\/p>\n<p>Following the amendments that entered into force on 11 February 2026, notification is required if either (i) the aggregate Turkish turnover of the transaction parties exceeds TRY 3 billion and the Turkish turnover of at least two of the parties each exceeds TRY 1 billion, or (ii) in acquisitions, the Turkish turnover of the transferred undertaking or assets exceeds TRY 1 billion and the worldwide turnover of at least one of the other parties exceeds TRY 9 billion. In transactions involving a T\u00fcrkiye-resident technology undertaking, the special technology undertaking rule may apply, in which case the usual TRY 1 billion local threshold is replaced by a TRY 250 million threshold for the relevant undertaking.<\/p>\n<p>As regards foreign investment, T\u00fcrkiye does not have a general foreign direct investment screening regime of the type seen in some other jurisdictions. Foreign investment is generally governed by the liberal framework of the Foreign Direct Investment Law No. 4875, which is based on national treatment and a notification-based rather than approval-based system. However, investments in regulated sectors may still be subject to sector-specific approvals, licensing requirements or foreign ownership restrictions under special legislation.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What is the process, and internal approvals needed, for a company issuing shares to investors in the jurisdiction and are there any related taxes or notary (or other fees) payable?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>In T\u00fcrkiye, venture-backed companies are typically incorporated as JSCs, and a primary venture investment is usually implemented by way of a capital increase. Under the ordinary capital system, the board of directors initiates the process and the general assembly resolves on the capital increase and the corresponding amendment to the articles of association. The capital increase becomes legally effective upon registration with the trade registry.<\/p>\n<p>Existing shareholders have statutory pre-emptive rights in proportion to their holdings, and those rights may only be restricted or removed for a just cause. Where pre-emptive rights are restricted or excluded, the relevant general assembly resolution requires the affirmative vote of shareholders representing at least 60% of the share capital. However, if the transaction also involves the creation of a new class of preferred shares or other privileged rights through an amendment to the articles of association, the stricter quorum under Article 421\/3-b of the Turkish Commercial Code applies: the meeting must be attended by shareholders or representatives holding at least 75% of the share capital, and the resolution must be passed by the affirmative vote of the same majority.<\/p>\n<p>For cash capital increases, at least one quarter of the nominal value of the subscribed shares must generally be paid before registration, and the balance may be paid within 24 months. In practice, however, venture investors typically fund not only the nominal amount but also a substantial share premium. This is commercially important because venture investments are commonly made at a valuation above nominal value, and, from a Turkish tax perspective, share premium (emission premium) is generally exempt from corporate tax.<\/p>\n<p>As a matter of process, the general assembly minutes and the amended articles of association are filed with the trade registry for registration and announcement. In practice, a ministry representative is also required at general assembly meetings whose agenda includes a capital increase. In addition, a 0.04% Competition Authority fee is payable on the amount of the capital increase, and trade registry, gazette, notarial, apostille, translation and power-of-attorney costs may also arise depending on the transaction mechanics and the profile of the investors. Sector-specific approvals may further be required in regulated industries.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">How prevalent is participation from investors that are not venture capital funds, including angel investors, family offices, high net worth individuals, and corporate venture capital?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Participation from investors other than traditional venture capital funds is significant in T\u00fcrkiye, particularly at pre-seed and seed stage. The market is not driven solely by institutional VC funds. Angel investors, angel networks, family offices, high-net-worth individuals and, increasingly, corporate investors all play a visible role in the funding landscape, especially in early-stage and technology-focused transactions. Official policy materials similarly describe the Turkish startup ecosystem as comprising the full spectrum of funding-side stakeholders, from business angels to venture capital and private equity investors.<\/p>\n<p>Angel investors remain especially important at the earliest stages, where companies may not yet be ready for a conventional institutional round. Their role is reinforced by T\u00fcrkiye\u2019s licensed angel investor regime, which is intended to encourage qualifying individual investment into startups. In practice, angel participation is commonly seen not only in standalone early-stage rounds, but also in syndicates, bridge financings and co-investments.<\/p>\n<p>Corporate participation is also an increasingly important feature of the Turkish venture market. Major Turkish conglomerates, telecom operators and commercial banks have established dedicated investment, venture or innovation arms, reflecting a market in which strategic capital now sits alongside purely financial venture capital. Family offices and high-net-worth individuals also participate meaningfully, whether through direct investments, syndicates or other investment structures, although their activity is generally less transparent in public deal reporting than that of institutional funds or corporate investors. It is also worth noting that equity-based crowdfunding has become a recognised, regulated alternative route for early-stage companies. Overall, non-fund investors are an important part of the Turkish venture ecosystem, but their role is most pronounced in earlier-stage financings, syndicates and co-investment structures, whereas larger Series A and later rounds are more commonly led by institutional venture capital funds, strategic corporates and, where relevant, international investors.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What is the typical investment period for a venture capital fund in the jurisdiction?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>There is no single statutory investment period applicable to all venture capital funds in T\u00fcrkiye. Under Turkish law and Capital Markets Board regulations, the relevant timing is determined primarily by the fund documents, the structure of the vehicle and the investment strategy, rather than by a uniform rule imposed across the market.<\/p>\n<p>In practice, however, Turkish venture funds broadly follow the familiar long-term closed-end model. The overall life of a venture capital fund is typically structured over a multi-year horizon, and Turkish market commentary commonly places that overall term in the range of seven to ten years. Within that overall term, the active investment period is usually concentrated in the earlier years of the fund and, in practice, will often span approximately three to five years, although this ultimately depends on fund design rather than a fixed statutory rule. The later years are used more heavily for follow-on investments, portfolio support and exit execution.<\/p>\n<p>Accordingly, the typical investment period in T\u00fcrkiye is driven less by mandatory law than by fund design and market expectations. In that respect, T\u00fcrkiye does not materially depart from international venture fund practice: capital deployment is typically front-loaded, while the remainder of the fund\u2019s term is used more heavily for follow-on investments, portfolio value creation and exit strategies.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What are the key investment terms which a venture investor looks for in the jurisdiction including representations and warranties, class of share, board representation (and observers), voting and other control rights, redemption rights, anti-dilution protection and information rights?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>In T\u00fcrkiye, venture investors generally seek a familiar package of economic, governance and exit protections. These rights are typically documented in both the shareholders\u2019 agreement and the articles of association, particularly where the relevant right must also be reflected in the constitutional documents under Turkish corporate law.<\/p>\n<p>The key investment terms usually include a full set of representations and warranties, preferred share rights, liquidation preference, anti-dilution protection, board representation or observer rights, veto and reserved matter protections, pre-emptive and pro rata rights, information rights and exit rights such as tag-along and drag-along rights. Representations and warranties are usually extensive and cover the company\u2019s legal, financial, tax and operational position, with particular focus on matters such as intellectual property, employment, data protection, compliance and litigation. Information rights are also standard and typically include periodic financial statements, annual budgets, business plans, management accounts and, depending on the transaction, access to books and records, audit rights and access to management.<\/p>\n<p>Investors typically subscribe for preferred shares carrying the main economic and governance privileges. Liquidation preference is one of the core protections and is usually structured on a non-participating basis. Board representation is also common, especially for lead investors, while smaller or co-investors may instead seek observer rights. Investors also generally negotiate a list of reserved matters requiring investor consent, covering matters such as amendments to the articles of association, capital increases, new share issuances, option pools, major indebtedness, material transactions, M&amp;A, significant expenditures and senior management changes.<\/p>\n<p>Anti-dilution protection is also standard, particularly in relation to down rounds. In practice, these protections are often implemented through founder transfers or additional subscriptions structured in a manner compatible with Turkish law.<\/p>\n<p>Redemption rights are generally less central in Turkish venture practice, as Turkish capital maintenance rules limit a company\u2019s ability to acquire its own shares. Investors therefore tend to place greater emphasis on liquidation preference, anti-dilution protection, veto rights, information rights and exit protections such as tag-along and drag-along rights.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What are the key features of the liability regime (e.g. monetary damages vs. compensatory capital increase) that apply to venture capital investments in the jurisdiction?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>In T\u00fcrkiye, the liability regime applicable to venture capital investments is primarily contractual and, in principle, damages-based. Breach of representations and warranties, undertakings or shareholder covenants is typically addressed through monetary compensation, supported by indemnity provisions and, where agreed, contractual penalty mechanisms. In practice, the parties usually allocate risk through negotiated limitations such as caps, de minimis and basket thresholds, survival periods and carve-outs for fraud or wilful misconduct.<\/p>\n<p>That said, Turkish venture transactions also make use of equity-based corrective mechanisms in specific contexts. In particular, anti-dilution and similar make-whole protections may be implemented either through founder share transfers at nominal or no value, or through additional subscriptions by the investor in a subsequent capital increase at nominal value. These mechanisms are recognised in market practice, but they are better understood as transaction-specific adjustment tools than as the general liability model.<\/p>\n<p>Accordingly, the Turkish position is not one of compensatory capital increase as the default remedy. The primary model remains monetary indemnification, while equity-based remedies are used selectively where the commercial bargain specifically calls for a share-based correction rather than a cash payment. This is particularly relevant in startup transactions, where founders may have limited liquidity and the parties may therefore prefer a contractual equity adjustment mechanism for certain types of breach or dilution event.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">How common are arrangement\/ monitoring fees for investors in the jurisdiction?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>In the Turkish venture capital market, arrangement and monitoring fees are uncommon. While such fees may be seen in more traditional private equity or control-style transactions, venture capital investors in T\u00fcrkiye do not usually charge early-stage portfolio companies separate arrangement or monitoring fees. Their economics are more typically driven by equity upside on exit, while management and performance-based fees sit at fund level rather than portfolio-company level under the Turkish fund framework.<\/p>\n<p>That said, investor costs are often addressed in other ways. In particular, transaction documents may require the company to bear agreed legal, financial, tax and due diligence costs associated with the investment, usually subject to negotiation and often with a cap. In practice, that is much more common than a recurring monitoring fee.<\/p>\n<p>Board remuneration should also be distinguished from monitoring fees. Under Turkish law, board members may be granted attendance fees, wages, bonuses or similar financial rights if provided for in the articles of association or resolved by the general assembly. In venture transactions, however, this is a separate corporate law issue and should not be confused with a PE-style monitoring fee charged by the investor.<\/p>\n<p>In strategic corporate investments, the parties may also agree separate commercial or service arrangements. However, these are generally treated separately and not as a traditional arrangement or monitoring fee in the private equity sense.<\/p>\n<p>Accordingly, arrangement and monitoring fees are not a standard feature of Turkish venture capital transactions. Where a company-level payment obligation is agreed, it is more likely to relate to one-off transaction expenses than to an ongoing fee for monitoring the investment.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">Are founders and senior management typically subject to restrictive covenants following ceasing to be an employee and\/or shareholder and, if so, what is their general scope and duration?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Yes. In Turkish venture capital transactions, founders and senior management are typically subject to restrictive covenants, both during their involvement with the company and for a period after they cease to be employees and\/or shareholders. These restrictions usually include non-compete, non-solicitation of employees and customers, confidentiality and, in some cases, non-disparagement undertakings. They are commonly included in shareholders\u2019 agreements and, where relevant, in employment or management agreements.<\/p>\n<p>As a matter of Turkish law, post-termination non-compete obligations in the employment context must be reasonable and limited in terms of subject matter, geography and duration, and they should not jeopardise the employee\u2019s economic future. Under the Turkish Code of Obligations, the general rule is that a post-employment non-compete should not exceed two years, unless special circumstances justify a longer period. Turkish courts also have the power to narrow overly broad restrictions.<\/p>\n<p>In venture practice, founders are often subject to broader covenant packages than ordinary employees because they are also shareholders and key value drivers of the business. Accordingly, non-compete and non-solicitation covenants are commonly structured to apply throughout the period of employment or shareholding and to continue for a further period after departure, often in the range of 12 to 24 months, depending on the role of the individual, the nature of the business and the scope of the restriction. Confidentiality obligations are typically longer-lasting and may survive for several years or, in the case of trade secrets, for so long as the relevant information remains confidential.<\/p>\n<p>Turkish law does not generally require separate financial compensation as a condition for the validity of a post-termination non-compete in the employment context. However, the restriction must remain reasonable in scope, duration and geography, and must not unfairly jeopardise the individual\u2019s economic future. In practice, the existence of a broader commercial bargain may be relevant to the overall assessment, particularly in the case of founders who are also shareholders and parties to the investment documentation.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">How are employees typically incentivised in venture capital backed companies (e.g. share options or other equity-based incentives)?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>In T\u00fcrkiye, employees in venture capital backed companies are typically incentivised through a combination of actual equity awards, option-style arrangements and virtual equity structures, but these are generally implemented on a bespoke contractual basis rather than under a dedicated statutory ESOP regime. Unlike jurisdictions that offer a specific tax-advantaged framework for employee stock options, Turkish law does not currently provide a standalone corporate and tax regime exclusively for ESOPs.<\/p>\n<p>In practice, phantom share or other virtual equity plans remain very common, particularly for broader employee participation. These arrangements usually entitle the employee to a cash benefit linked to the value of the company or to an exit event, without giving immediate shareholder status. They are often preferred because they avoid immediate shareholder status, cap table fragmentation and the corporate mechanics associated with actual share issuances and transfers under Turkish law, while still allowing the company to align employees with value creation.<\/p>\n<p>Where actual equity or option-style participation is used, the structure requires more careful planning under Turkish corporate law. A JSC may acquire its own shares only within statutory limits, generally up to 10% of its share capital and subject to reserve requirements. For that reason, employee incentive pools are often created from founders\u2019 existing shares, or through specifically structured capital increases and transfer arrangements, rather than through a simple company-held option pool. These plans are usually accompanied by vesting, leaver provisions, exercise conditions and transfer restrictions.<\/p>\n<p>Tax has also become more relevant in structuring these plans. As a general matter, benefits derived from the grant or acquisition of shares may be treated as employment income. At the same time, the 2024 reform introducing an income tax exemption for certain shares granted free of charge or at a discount by qualifying techno-initiative companies has made real-share incentive structures more attractive than before, although it does not remove the broader corporate-law constraints that often lead Turkish startups to prefer virtual or hybrid models.<\/p>\n<p>Accordingly, the Turkish market does not rely on a single dominant model. Key employees and senior management are more likely to receive actual equity, option-style rights or founder-share based participation, usually subject to vesting and leaver mechanics, whereas broader employee groups are often incentivised through phantom equity or similar cash-settled plans. The overall approach is therefore recognisably venture-style, but more contractual and structurally tailored than in jurisdictions with a mature statutory ESOP framework.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What are the most commonly used vesting\/good and bad leaver provisions that apply to founders\/ senior management in venture capital backed companies?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>In T\u00fcrkiye, vesting and good leaver \/ bad leaver provisions are commonly used for founders and, increasingly, for senior management in venture capital backed companies. Because founders usually hold their shares from incorporation, these arrangements are typically structured as reverse vesting mechanisms, supported by call options, transfer undertakings or similar contractual buy-back rights.<\/p>\n<p>The most common model is a four-year vesting schedule with a one-year cliff. If the founder leaves during the cliff period, none of the relevant shares are treated as vested. After the cliff, vesting usually continues monthly or quarterly over the remainder of the vesting period.<\/p>\n<p>A good leaver will generally include departures for no-fault reasons, such as death, incapacity or termination without cause, in which case vested shares are usually retained and only unvested shares are transferred back or repurchased. A bad leaver will typically include dismissal for cause, fraud, material breach or breach of restrictive covenants, in which case unvested shares are commonly transferred back at nominal value and, in some cases, vested shares may also be subject to transfer at nominal value or a discounted price.<\/p>\n<p>In practice, these provisions are usually combined with call options, repurchase mechanics, leaver definitions and, in some cases, acceleration clauses, all of which are negotiated in detail in the shareholders\u2019 agreement.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What have been the main areas of negotiation between investors, founders, and the company in the investment documentation, over the last 24 months?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Over the last 24 months, the main areas of negotiation in Turkish venture capital documentation have been valuation, downside protection, governance and control rights, founder alignment and exit mechanics. The market has remained selective, and negotiations have therefore become more detailed around the allocation of economic risk and post-closing control. In Turkish practice, this has meant closer focus on liquidation preference, anti-dilution protection, board composition, investor vetoes, information rights, founder vesting and good leaver\/bad leaver treatment, rather than any major departure from internationally familiar venture terms.<\/p>\n<p>Valuation and downside protection have been among the most heavily negotiated points. Where founders and investors have taken different views on pricing, the discussion has usually extended beyond headline valuation to the detailed operation of liquidation preference, anti-dilution and future participation rights. In Turkish deals, 1x non-participating liquidation preference remains the more common baseline, while weighted-average anti-dilution is generally more common than more aggressive formulations. At the same time, bridge or deferred-pricing structures have attracted greater attention where the parties preferred to postpone a fully priced round. In those situations, the principal negotiation points have typically been valuation caps, discounts, conversion mechanics and the interaction between the bridge instrument and the next equity financing.<\/p>\n<p>Governance has also remained central. Investors have continued to negotiate in detail over board representation, observer rights, reserved matters, information rights and approval thresholds for future fundraisings, major expenditures, deviations from the business plan, senior management changes and strategic transactions. This is particularly important in T\u00fcrkiye because the key protections are usually split between the shareholders\u2019 agreement and the articles of association, and the enforceability of investor rights often depends on how the relevant mechanism is structured in the constitutional documents.<\/p>\n<p>Founder alignment has been another major area of negotiation. Reverse vesting, good leaver\/bad leaver treatment, non-compete and non-solicitation undertakings, lock-up style transfer restrictions and intellectual property assignment have all remained heavily negotiated, especially in founder-led businesses where the investment thesis remains closely tied to the continued involvement of the founding team. In Turkish practice, these provisions are rarely treated as boilerplate; they are usually tailored in detail because the mechanics of founder departures, share transfers and vesting need to work within Turkish corporate law constraints.<\/p>\n<p>Exit mechanics have also continued to attract significant attention. Drag-along and tag-along rights, the thresholds for forcing or blocking a sale, the allocation of sale proceeds among different share classes and the interaction between liquidation preference and the exit waterfall have all remained active negotiation topics. As a result, the recent trend in T\u00fcrkiye has been towards more detailed drafting around downside protection, governance, founder retention and exit execution, rather than towards wholly new concepts.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">How prevalent is the use of convertible debt (e.g. convertible loan notes) and advance subscription agreement\/ SAFEs in the jurisdiction?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Convertible debt is now a recognised and increasingly common instrument in T\u00fcrkiye, particularly in seed, bridge and interim financings. SAFE-style and advance subscription\/future equity structures, including advance capital arrangements (sermaye avans\u0131), are also increasingly used, but they remain less standardised than in the US or the UK. In practice, these instruments are typically used where the parties wish to defer valuation, bridge the company to the next priced round or simplify the initial funding process.<\/p>\n<p>The Turkish-law position, however, is still driven by corporate mechanics rather than by a standalone statutory SAFE regime. A SAFE is not a specifically regulated instrument under the Turkish Commercial Code, and a convertible instrument does not convert into shares automatically in the way market participants may expect in some other jurisdictions. When conversion is to be implemented, the relevant corporate steps still need to be taken, including the necessary capital increase mechanics, shareholder approvals and trade registry formalities. For that reason, Turkish practice relies on tailored documentation, most commonly convertible loan agreements and various future equity\/advance capital structures adapted to Turkish law.<\/p>\n<p>The regulatory direction has nonetheless been clearly supportive over the last two years. In September 2024, the Capital Markets Board amended the VCIF communiqu\u00e9 so that agreements granting, or to grant in the future, a right to become a shareholder in a venture company are recognised as venture capital investments; this expressly brought SAFE-like agreements into the regulatory framework for VCIFs. In addition, the Capital Movements Circular now provides a specific foreign-currency regime for share-convertible debt agreements entered into with foreign venture capital funds, collective investment undertakings other than securities funds, or licensed foreign angel investors, and for certified teknogiri\u015fim companies (tech-initiative companies) the period for adding the transferred amount to capital has been extended from 12 months to 36 months.<\/p>\n<p>Accordingly, the better view is that convertible debt is already fairly common in Turkish venture practice, while SAFE-style and advance subscription structures are increasingly prevalent but still more bespoke. They are no longer unusual instruments in T\u00fcrkiye, particularly in early-stage and bridge financings, but they still need to be documented and implemented with closer attention to Turkish corporate and regulatory requirements than in more mature venture jurisdictions.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What are the customary terms of convertible debt (e.g. convertible loan notes) and advance subscription agreement\/ SAFEs in the jurisdiction and are there standard from documents?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>In T\u00fcrkiye, the customary commercial terms of convertible debt and SAFE-style\/advance subscription structures are broadly familiar to international venture investors, but their legal implementation is more bespoke and more closely tied to Turkish corporate law mechanics. There is no Turkish statutory SAFE form and no market-wide standard document set equivalent to the Y Combinator SAFE or the BVCA templates. In practice, parties usually work from internationally familiar concepts and adapt them to Turkish law.<\/p>\n<p>Convertible loan agreements typically include the principal amount, interest, maturity, conversion triggers, valuation cap and\/or discount, and the treatment of the instrument if no qualifying financing occurs by maturity. They also usually address what happens on a liquidity event or exit, whether the investor converts or is repaid, and how the investor accedes to the investment documentation of the next equity round. Under Turkish law, however, conversion is not self-executing in the way some foreign investors may expect: the relevant capital increase, shareholder approvals, any necessary waiver or restriction of pre-emptive rights, set-off mechanics where applicable, and trade registry steps must still be implemented.<\/p>\n<p>SAFE-style and advance capital structures are usually lighter in form and are mainly used to defer valuation and simplify the initial funding process. Their key terms generally include the investment amount, valuation cap and\/or discount, the definition of the next equity financing, and the treatment of liquidity and dissolution events. In practice, cap-only, discount-only, cap-plus-discount and MFN-style formulations are all conceptually familiar, although Turkish documents are usually localised and heavily negotiated rather than used on an off-the-shelf basis.<\/p>\n<p>Accordingly, the Turkish position is not that these instruments are unusual, but that they are increasingly common while remaining more bespoke than in more mature venture markets. The commercial terms are broadly recognisable, but there are no standard Turkish model forms in general use, and the documents are usually prepared from fund or law firm precedents tailored to Turkish law.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">How prevalent is the use of venture or growth debt as an alternative or supplement to equity fundraisings or other debt financing in the last 24 months?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Venture and growth debt remain relatively uncommon in T\u00fcrkiye when compared with equity financings and should still be regarded primarily as supplementary tools rather than mainstream alternatives to equity. In the Turkish startup ecosystem, companies seeking non-equity financing have more frequently relied on convertible debt, SAFE-like instruments and other deferred-pricing structures than on a developed standalone venture debt market. This reflects a broader preference for instruments that defer valuation discussions and reduce immediate dilution, rather than for conventional interest-bearing borrowing.<\/p>\n<p>Over the last 24 months, debt-type financing has become somewhat more visible, particularly in bridge or interim financing contexts where founders seek to extend runway pending a priced round. Even so, the market has developed more clearly in favour of convertible and future-equity structures than classic venture or growth debt. The 2024 amendments to the VCIF regime, which expressly recognise agreements granting a future right to become a shareholder as venture capital investments, are consistent with that direction. Accordingly, while venture and growth debt are gradually gaining visibility in T\u00fcrkiye, they remain niche products, used more often in bridge financings or by more mature, revenue-generating companies capable of servicing debt obligations.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What are the customary terms of venture or growth debt in the jurisdiction and are there standard form documents?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>In T\u00fcrkiye, venture or growth debt is typically documented on a bespoke basis, and there is no market-wide standard form specifically used for this product. Where it is used, the documents are generally closer to tailored loan and security documentation than to a standard venture capital form, although cross-border lenders and counsel may work from LMA-style concepts and adapt them to Turkish law.<\/p>\n<p>The customary terms are broadly those of a tailored term loan or other secured debt facility, adapted to the company\u2019s stage, cash profile and funding structure. These usually include the facility amount, drawdown conditions, maturity, repayment profile, interest and default interest, fees, representations and warranties, undertakings, information covenants, events of default and remedies. Where the borrower is a Turkish company, any foreign-currency lending aspects also need to be assessed against the applicable FX borrowing restrictions and the Capital Movements Circular framework.<\/p>\n<p>If security is taken, it is usually structured through Turkish-law security documents over assets that can be effectively collateralised, such as shares, receivables, bank accounts, movable assets or commercial enterprise assets, depending on the deal. Turkish-law perfection rules are critical, and security over Turkish assets cannot simply be copied from foreign precedents without local adaptation.<\/p>\n<p>There is also no settled Turkish standard for a classic venture-debt \u201cequity kicker\u201d package. If the lender expects upside participation, that usually needs to be structured separately through Turkish-law arrangements rather than assumed from an off-the-shelf venture debt precedent. Accordingly, the Turkish position is that the terms are broadly familiar from a lending perspective, but the product is still documented through lender-specific or counsel-specific precedents rather than a dedicated standard document suite.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What are the current market trends for venture capital in the jurisdiction (including the exits of venture backed companies) and do you see this changing in the next year?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>The Turkish venture capital market is currently active but selective. According to the KPMG\u2019s startup review, in 2025, T\u00fcrkiye recorded approximately 360 startup deals worth USD 1.4 billion. While deal count remained robust, aggregate value fell from USD 2.6 billion in 2024, pointing to a market with smaller average ticket sizes, fewer outsized rounds and greater valuation discipline.<\/p>\n<p>A defining feature of the market remains the funding gap between seed and later-stage rounds. Seed activity continues, supported in part by the large number of local VCIFs but the transition from seed to Series A and B remains structurally difficult. That remains one of the most important features of the Turkish ecosystem and continues to affect both fundraising strategy and exit timing.<\/p>\n<p>Sectorally, venture activity remains concentrated in technology-led verticals. Technology is the most active sector by deal count, and gaming remains one of T\u00fcrkiye\u2019s established strengths. At the same time, investor attention is increasingly shifting toward AI, fintech, defence-related technologies and other scalable software-led businesses. Deloitte\u2019s 2025 review similarly notes that venture capital activity remained concentrated in technology, gaming and fintech.<\/p>\n<p>As regards exits, trade sales and strategic acquisitions remain more realistic than IPOs for most venture-backed Turkish companies. The Turkish market has seen meaningful strategic transactions and a healthier M&amp;A backdrop, but the broader pattern remains that liquidity is more likely to come from M&amp;A and secondary transactions than from a deep and consistent IPO channel. Deloitte\u2019s 2025 review also records several financial-investor exits and lists Uber\u2019s acquisition of an 85% stake in Trendyol Go among the year\u2019s major transactions, which is consistent with the continued importance of strategic M&amp;A as an exit route.<\/p>\n<p>Foreign capital remains important, particularly for larger financings and exits, although the market is not solely foreign-driven. Deloitte reports that, in the broader 2025 Turkish M&amp;A market, domestic investors completed 361 transactions worth USD 9.3 billion, while foreign investors completed 89 transactions worth USD 6.9 billion. That pattern is broadly consistent with the venture market as well: local capital is essential for ecosystem continuity, but larger growth financings and strategic exits still depend heavily on international investor interest.<\/p>\n<p>Over the next year, the better view is one of cautious continuity rather than sharp change. The market is likely to remain selective, with investors continuing to favour companies that can demonstrate disciplined unit economics, credible paths to scale and defensible technology. AI, fintech and defence-related technologies are likely to remain prominent. Exit conditions may improve gradually if the stronger M&amp;A environment is sustained, but for the near-term trade sales, strategic acquisitions and secondary transactions are still likely to remain more common than IPO-led exits for Turkish venture-backed companies.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">Are any developments anticipated in the next 12 months, including any proposed legislative reforms that are relevant for venture capital investor in the jurisdiction?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>No single omnibus legislative reform specific to venture capital is currently visible in T\u00fcrkiye, but several recent and anticipated developments are relevant to venture investors. The most important near-term issue is the continued implementation of the September 2024 amendments to the VCIF Communiqu\u00e9, which materially broadened the Turkish fund framework. Those amendments introduced umbrella funds and sub-funds, allowed VCIFs to operate as fund-of-funds, lowered the T\u00fcrkiye-asset threshold for foreign-incorporated portfolio companies from 80% to 51%, and expressly recognised agreements granting a future right to become a shareholder as qualifying venture capital investments. That last point is particularly important for SAFE-style and similar instruments.<\/p>\n<p>A second important development is the new framework for public participation in venture capital funds. The Regulation on Participation in Venture Capital Funds and Venture Capital Practices, which entered into force on 28 November 2025, establishes the framework for Ministry-supported participation in venture capital funds, including eligibility, application, monitoring and related procedures. In practical terms, this points to a more structured pipeline for public-backed capital into technology and innovation-focused funds over the next 12 months.<\/p>\n<p>The broader policy direction also remains supportive. The 2030 Industry and Technology Strategy expressly refer to strengthening the startup ecosystem, expanding venture capital mechanisms and supporting technology entrepreneurship as part of T\u00fcrkiye\u2019s wider industrial policy. This suggests continued institutional support for venture funding channels rather than a retreat from the current approach.<\/p>\n<p>Accordingly, the better view is that the next 12 months are likely to bring implementation and refinement rather than a fundamental legislative reset. In particular, we would expect continued practical use of the expanded VCIF framework, greater visibility of public-backed venture funding under the new Ministry regulation, and further policy attention on technology entrepreneurship and scale-up finance. The direction of travel remains broadly supportive of venture capital, even if the changes are arriving through targeted regulatory measures rather than through a single new venture capital law.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\r\n<div class=\"word-count-hidden\" style=\"display:none;\">Estimated word count: <span class=\"word-count\">6691<\/span><\/div>\r\n\r\n\t\t\t<\/ol>\r\n\r\n<script type=\"text\/javascript\" src=\"\/wp-content\/themes\/twentyseventeen\/src\/jquery\/components\/filter-guides.js\" async><\/script><\/div>"}},"_links":{"self":[{"href":"https:\/\/my.legal500.com\/guides\/wp-json\/wp\/v2\/comparative_guide\/140234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/my.legal500.com\/guides\/wp-json\/wp\/v2\/comparative_guide"}],"about":[{"href":"https:\/\/my.legal500.com\/guides\/wp-json\/wp\/v2\/types\/comparative_guide"}],"wp:attachment":[{"href":"https:\/\/my.legal500.com\/guides\/wp-json\/wp\/v2\/media?parent=140234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}